rs2027515

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000375.3(UROS):​c.394+150A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.758 in 714,674 control chromosomes in the GnomAD database, including 207,539 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 40594 hom., cov: 32)
Exomes 𝑓: 0.77 ( 166945 hom. )

Consequence

UROS
NM_000375.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.94
Variant links:
Genes affected
UROS (HGNC:12592): (uroporphyrinogen III synthase) The protein encoded by this gene catalyzes the fourth step of porphyrin biosynthesis in the heme biosynthetic pathway. Defects in this gene cause congenital erythropoietic porphyria (Gunther's disease). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 10-125807263-T-C is Benign according to our data. Variant chr10-125807263-T-C is described in ClinVar as [Benign]. Clinvar id is 1276252.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.785 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UROSNM_000375.3 linkc.394+150A>G intron_variant Intron 6 of 9 ENST00000368797.10 NP_000366.1 P10746A0A0S2Z4T8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UROSENST00000368797.10 linkc.394+150A>G intron_variant Intron 6 of 9 1 NM_000375.3 ENSP00000357787.4 P10746

Frequencies

GnomAD3 genomes
AF:
0.724
AC:
110081
AN:
151972
Hom.:
40574
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.617
Gnomad AMI
AF:
0.809
Gnomad AMR
AF:
0.623
Gnomad ASJ
AF:
0.745
Gnomad EAS
AF:
0.704
Gnomad SAS
AF:
0.775
Gnomad FIN
AF:
0.840
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.791
Gnomad OTH
AF:
0.716
GnomAD4 exome
AF:
0.767
AC:
431568
AN:
562584
Hom.:
166945
Cov.:
7
AF XY:
0.769
AC XY:
231603
AN XY:
301138
show subpopulations
African (AFR)
AF:
0.620
AC:
9376
AN:
15128
American (AMR)
AF:
0.585
AC:
17832
AN:
30474
Ashkenazi Jewish (ASJ)
AF:
0.751
AC:
13551
AN:
18048
East Asian (EAS)
AF:
0.681
AC:
21650
AN:
31796
South Asian (SAS)
AF:
0.775
AC:
44901
AN:
57948
European-Finnish (FIN)
AF:
0.846
AC:
28991
AN:
34276
Middle Eastern (MID)
AF:
0.690
AC:
1690
AN:
2450
European-Non Finnish (NFE)
AF:
0.792
AC:
270916
AN:
342192
Other (OTH)
AF:
0.749
AC:
22661
AN:
30272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
5229
10458
15687
20916
26145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1900
3800
5700
7600
9500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.724
AC:
110150
AN:
152090
Hom.:
40594
Cov.:
32
AF XY:
0.726
AC XY:
53952
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.617
AC:
25589
AN:
41460
American (AMR)
AF:
0.623
AC:
9513
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.745
AC:
2582
AN:
3468
East Asian (EAS)
AF:
0.704
AC:
3643
AN:
5178
South Asian (SAS)
AF:
0.774
AC:
3724
AN:
4810
European-Finnish (FIN)
AF:
0.840
AC:
8886
AN:
10584
Middle Eastern (MID)
AF:
0.619
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
0.791
AC:
53778
AN:
68008
Other (OTH)
AF:
0.718
AC:
1515
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1503
3006
4508
6011
7514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.736
Hom.:
18096
Bravo
AF:
0.702
Asia WGS
AF:
0.731
AC:
2546
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.051
DANN
Benign
0.46
PhyloP100
-3.9
PromoterAI
0.038
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2027515; hg19: chr10-127495832; COSMIC: COSV64223420; API